| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 313.837.943 $ | +157.283.041 $ | +726,6 % | 11 | 286.690.341 $ | +211.075.941 $ | +387,0 % | 10 | 79.416.423 $ | +34.822.664 $ | +403,7 % | 4 | ||||
| UNITED THERAPEUTICS Corp | UTHR | → 0 | Neutral | 51.887.529 $ | +47.015.029 $ | +964,9 % | 1 | ||||||||
| Viking Therapeutics, Inc. | VKTX | → 0 | Neutral | 38.539.758 $ | -8.687.598 $ | -18,4 % | 1 | 47.227.356 $ | +31.491.181 $ | +200,1 % | 1 | ||||
| VERTEX PHARMACEUTICALS INC / MA | VRTX | → 0 | Neutral | 43.287.588 $ | -1.277.700 $ | -2,9 % | 1 | 44.565.288 $ | +40.113.288 $ | +901,0 % | 1 | ||||
| CAPRICOR THERAPEUTICS, INC. | CAPR | → 0 | Sehr schwach | 31.359.150 $ | +12.012.127 $ | +62,1 % | 1 | 19.347.023 $ | +17.184.023 $ | +794,5 % | 1 | ||||
| BridgeBio Pharma, Inc. | BBIO | → 0 | Sehr schwach | 31.330.304 $ | +24.505.388 $ | +359,1 % | 1 | ||||||||
| Abivax S.A. | ABVX | → 0 | Schwach | 30.487.262 $ | +20.286.290 $ | +198,9 % | 1 | ||||||||
| FINANCIAL COUNSELORS INC | → 0 | 30.482.500 $ | +22.189.500 $ | +267,6 % | 1 | ||||||||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Neutral | 29.650.844 $ | +24.350.844 $ | +459,4 % | 1 | ||||||||
| Liquidia Corp | LQDA | → 0 | Neutral | 26.874.654 $ | +26.119.978 $ | +3.461,1 % | 1 | ||||||||
| JOHNSON & JOHNSON | JNJ | → 0 | Sehr stark | 24.098.086 $ | +24.098.086 $ | 1 | |||||||||
| Avidity Biosciences, Inc. | RNA | → 0 | 23.658.640 $ | +13.633.183 $ | +136,0 % | 1 | |||||||||
| Jazz Pharmaceuticals plc | JAZZ | → 0 | Neutral | 17.901.000 $ | -4.918.852 $ | -21,6 % | 1 | 22.819.852 $ | +6.427.177 $ | +39,2 % | 1 | ||||
| SOLENO THERAPEUTICS INC | SLNO | → 0 | 22.127.508 $ | -1.678.747 $ | -7,1 % | 1 | |||||||||
| Revolution Medicines, Inc. | RVMD | → 0 | Schwach | 20.069.677 $ | +17.121.034 $ | +580,6 % | 1 | ||||||||
| Apogee Therapeutics, Inc. | APGE | → 0 | Schwach | 18.727.825 $ | +2.793.997 $ | +17,5 % | 1 | ||||||||
| Nuveen, LLC | → 0 | 18.565.000 $ | +18.565.000 $ | 1 | |||||||||||
| INVESCO QQQ TRUST, SERIES 1 | QQQ | → 0 | 18.429.300 $ | +18.429.300 $ | 1 | ||||||||||
| uniQure N.V. | QURE | → 0 | Schwach | 17.511.000 $ | +16.059.846 $ | +1.106,7 % | 1 | ||||||||
| INCYTE CORP | INCY | → 0 | Stark | 17.264.337 $ | +7.387.337 $ | +74,8 % | 1 | ||||||||
| REGENERON PHARMACEUTICALS, INC. | REGN | → 0 | Stark | 16.958.063 $ | +14.014.388 $ | +476,1 % | 1 | ||||||||
| Kodiak Sciences Inc. | KOD | → 0 | Schwach | 16.775.163 $ | +15.947.547 $ | +1.926,9 % | 1 | ||||||||
| 313.837.943 $ | +157.283.041 $ | +726,6 % | 11 | 286.690.341 $ | +211.075.941 $ | +387,0 % | 10 | 79.416.423 $ | +34.822.664 $ | +403,7 % | 4 | ||||